Immix Biopharma | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Immix Biopharma | 424B5: Prospectus
Immix Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-AIGH Capital Management, LLC(5.8%),Orin H(5.8%)
Immix Biopharma | 8-K: Current report
Immix Biopharma | 424B5: Prospectus
Immix Biopharma | 8-K: Current report
Immix Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Hsu Jason
Immix Biopharma: Q3 2023 Earnings Report
Immix Biopharma | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-CFO Morris Gabriel S
Immix Biopharma | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Rachman Ilya M
Immix Biopharma | EFFECT: Others
Immix Biopharma | CORRESP: CORRESP
Immix Biopharma | UPLOAD: Others
Immix Biopharma | S-3: Registration statement for specified transactions by certain issuers
Immix Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Hsu Jason
Immix Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Ng Carey
Immix Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Adams Helen C.
Immix Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Hsu Jason
Immix Biopharma | 4: Statement of changes in beneficial ownership of securities-Director BUCHAN MELISSA JANE
Immix Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Marquet Magda
No Data